HRT Financial’s Silexion Therapeutics Warrant SLXNW Stock Holding History

HRT Financial’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,260	Closed	–	–	4947
2025 Q4	$0	Buy	+21,260	New	+$755	﹤0.01%	4242

Other funds holding SLXNW

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

HRT Financial's SLXNW Position: Q1 2026 in Review

HRT Financial sold out of Silexion Therapeutics Warrant (SLXNW) in Q1 2026, closing a stake of 21,260 shares.

HRT Financial first reported a position in SLXNW in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

HRT Financial reported no remaining Silexion Therapeutics Warrant position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 21,260 Silexion Therapeutics Warrant shares in Q1 2026.
HRT Financial first reported a position in Silexion Therapeutics Warrant in Q4 2025 and held it in 1 quarter.
HRT Financial's Silexion Therapeutics Warrant position peaked at $0 in Q4 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.